15.05.2017 13:10:38
|
Thermo Fisher To Acquire Patheon In Approx. $7.2 Bln Deal - Quick Facts
(RTTNews) - Thermo Fisher Scientific Inc. (TMO) and Patheon N.V. (PTHN) announced their boards have approved Thermo Fisher's acquisition of Patheon. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per share in cash. The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2.0 billion of net debt.
The transaction is expected to be immediately and significantly accretive to Thermo Fisher's adjusted EPS by $0.30 in the first full year after close. Thermo Fisher expects to realize total synergies of approximately $120 million by year three following the close, consisting of approximately $90 million of cost synergies and approximately $30 million of adjusted operating income benefit from revenue-related synergies.
Thermo Fisher has entered into tender and support agreements with affiliates of JLL Partners and Royal DSM, whose collective holdings represent approximately 73% of Patheon shares, under which they will tender their shares in the transaction.
Patheon has an extensive network of state-of-the-art facilities primarily in North America and Europe, and approximately 9,000 professionals worldwide. The company generated 2016 revenue of approximately $1.9 billion and will become part of Thermo Fisher's Laboratory Products and Services Segment.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Patheon N.V.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Patheon N.V.mehr Analysen
Aktien in diesem Artikel
Thermo Fisher Scientific Inc | 544,40 | -0,18% |